Parkside Financial Bank & Trust - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 168 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Parkside Financial Bank & Trust ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$1,958
-2.9%
690.0%0.00%0.0%
Q4 2022$2,017
+0.8%
690.0%0.00%0.0%
Q3 2022$2,000
-50.0%
69
-14.8%
0.00%0.0%
Q2 2022$4,000
+300.0%
81
+170.0%
0.00%
Q1 2022$1,000
-66.7%
30
-52.4%
0.00%
-100.0%
Q4 2021$3,000
-25.0%
630.0%0.00%0.0%
Q3 2021$4,00063
+2000.0%
0.00%
Q2 2021$0
-100.0%
3
-93.5%
0.00%
-100.0%
Q1 2021$2,0000.0%460.0%0.00%0.0%
Q4 2020$2,000
+100.0%
46
+100.0%
0.00%
Q3 2020$1,00023
+155.6%
0.00%
Q1 2020$0
-100.0%
9
-30.8%
0.00%
Q4 2019$1,0000.0%130.0%0.00%
Q3 2019$1,0000.0%130.0%0.00%
Q2 2019$1,0000.0%130.0%0.00%
Q1 2019$1,00013
+8.3%
0.00%
Q4 2018$0
-100.0%
12
+50.0%
0.00%
Q3 2018$1,0000.0%80.0%0.00%
Q2 2018$1,0008
+60.0%
0.00%
Q1 2018$050.0%0.00%
Q4 2017$050.0%0.00%
Q3 2017$05
+25.0%
0.00%
Q2 2017$040.0%0.00%
Q1 2017$040.0%0.00%
Q4 2016$040.00%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Tri Locum Partners LP 94,922$4,063,0001.33%
Smith, Graham & Co., Investment Advisors, LP 277,572$11,880,0001.05%
Krensavage Asset Management, LLC 70,804$3,030,0001.03%
BRANDES INVESTMENT PARTNERS, LP 716,873$30,682,0000.68%
GLOBEFLEX CAPITAL L P 42,357$1,813,0000.33%
Zebra Capital Management LLC 6,472$277,0000.32%
Capital Impact Advisors, LLC 19,276$825,0000.27%
Hein Park Capital Management LP 31,977$1,369,0000.26%
CHARTWELL INVESTMENT PARTNERS, LLC 195,340$8,361,0000.25%
Stanley-Laman Group, Ltd. 24,000$1,027,0000.15%
View complete list of EAGLE PHARMACEUTICALS INC shareholders